Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06058169 · ClinicalTrials.gov registry record · NA
Effects of Home Base Whole-body Vibration in Osteoarthritis. (VIBE-Rx2)
A NA study of Osteoarthritis, Knee and Whole Body Vibration, sponsored by Augusta University.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06058169: Recruiting NA study of Osteoarthritis, Knee and Whole Body Vibration, sponsored by Augusta University.
NCT06058169 is a NA study of Osteoarthritis, Knee and Whole Body Vibration that is actively recruiting participants, run by Augusta University. The registered enrollment target is 30 participants, below the 497-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06058169, a NA study of Osteoarthritis, Knee and Whole Body Vibration, is actively recruiting participants, sponsored by Augusta University.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this proposal is to understand how the Vibrant Health Ultimate whole-body vibration (WBV) machine affects pain and inflammation in older adults. The investigators' hypothesize that sub-acute (12 weeks) WBV will lead to improvement in the level of knee pain and improve vascular function via a decrease in systemic inflammation.
Primary Outcome
change from baseline pain pressure threshold at 12 weeks. Pain Pressure Threshold (PPT) will be assessed using the Jtech Medical Echo Algometer. PPT is used to measure deep muscular tissue sensitivity. The test determines the amount of pressure over a given area in which a steadily increasing non-painful pressure stimulus turns into an uncomfortable or painful pressure sensation. The subject will lie supine. An investigator will assess PPT at the following sites: a) 2 cm below the medial edge of
Conditions Studied
Interventions
- DEVICE Sub Acute Whole Body Vibration Training
Study Locations (1)
Georgia
- Augusta University/Georgia Prevention Institute/ Laboratory of Integrative and Exercise Physiology - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-04-25 |
| Est. Completion | 2026-01-01 |
| Phase | NA |
What NCT06058169 shows while recruiting
NCT06058169 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 497-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 1 intervention - of which Sub Acute Whole Body Vibration Training is the first listed.
NCT06058169 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT06058169 about?
NCT06058169 is a clinical study titled "Effects of Home Base Whole-body Vibration in Osteoarthritis. (VIBE-Rx2)". The purpose of this proposal is to understand how the Vibrant Health Ultimate whole-body vibration (WBV) machine affects pain and inflammation in older adults. The investigators' hypothesize that sub-acute (12 weeks) WBV will lead to improvement in the level of knee pain and improve vascular functio...
What is the current status of trial NCT06058169?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-04-25. Estimated completion is 2026-01-01.
What conditions does trial NCT06058169 study?
This clinical trial studies the following conditions: Osteoarthritis, Knee, Whole Body Vibration.
What interventions are being tested in trial NCT06058169?
The interventions under investigation include: Sub Acute Whole Body Vibration Training (DEVICE).
Who is sponsoring clinical trial NCT06058169?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06058169 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06058169's enrollment target sits among peer trials
30 101st of 112 higher than 9 of 112 other Osteoarthritis, Knee trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis, Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mobilizing Hispanics With Knee Osteoarthritis
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
The Osteoarthritis Prevention Study
RECRUITING · NA
-
Navio Robotic Versus Conventional Total Knee Arthroplasty
RECRUITING · NA
-
MOTION Clinical Trial
RECRUITING · NA
-
Radio- KO Radiotherapy for Knee Osteoarthritis Clinical Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI